Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial

BACKGROUND: Carbapenem antibiotics are considered the treatment of choice for serious extended-spectrum beta-lactamase (ESBL)-producing Gram-negative bacteria (GNB) infections. The study objectives were to evaluate efficacy and safety of de-escalation therapy to ertapenem for treatment of infections...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Rattanaumpawan, Pinyo, Werarak, Peerawong, Jitmuang, Anupop, Kiratisin, Pattarachai, Thamlikitkul, Visanu
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5333449/
https://ncbi.nlm.nih.gov/pubmed/28249572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2284-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados